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The only established exogenous causal factor for cutaneous malig-
nant melanoma is exposure to sunlight (IARC, 1992). It is widely
believed that the ultraviolet (UV) radiation component of solar
radiation is responsible for this relationship. Although the transi-
tion from solar to artificial sources of UV radiation as a potential
risk factor for melanoma development is logical, only limited
attention has been paid to non-solar UV radiation and melanoma
risk. In addition, such studies may shed light on the effect of
different wavelength ranges on the melanoma development.
Concerning use of sunbeds and/or sunlamps and risk of
melanoma results so far have been somewhat inconclusive. Some
studies, including a previous study from us, have pointed out a
significant association between sunbed or sunlamp use and
melanoma (Swerdlow et al, 1988; Walter et al, 1990; Autier et al,
1994; Westerdahl et al, 1994). In another study only limited
evidence of a relation was found (Chen et al, 1998). In contrast,
other investigations have not been able to demonstrate such an
association (Gallagher et al, 1986; Holman et al, 1986; Æsterlind
et al, 1988b; MacKie et al, 1989).
We have conducted a new population-based, matched
case–control study of malignant melanoma in the South Swedish
Health Care Region to be able to address the issue further.
MATERIALS AND METHODS
The study identified 709 persons, aged 16–80 years, in the
South Swedish Health Care Region with a first histopathological
diagnosis of cutaneous invasive malignant melanoma between 1
January 1995 and 30 June 1997, according to the population-based
Regional Tumour Registry. The permission of the physician
responsible for the treatment of each patient was sought. In two
cases the physician did not respond, and in additional 33 cases the
patient was considered ineligible by the treating physician (18
were ineligible for psychological reasons, four had another serious
disease, three were dead, three refused to participate, two had
metastases, one was found to have the wrong diagnosis, one had
not been fully informed and one had moved). Thus, the case group
comprised 674 eligible persons.
For each of these cases two healthy controls, matched by sex,
age (within a year) and parish were selected by random sampling
from the National Population Registry of residents of the South
Swedish Health Care Region.
All eligible cases (n = 674) were mailed a comprehensive ques-
tionnaire including different epidemiological variables (medical
history, medicaments, family history, constitutional factors, educa-
tional level, UV radiation exposure, smoking habits and alcohol)
within 2 months following diagnosis. During the same time all
selected controls (n = 1348) were mailed an identical question-
naire. Non-responders were contacted twice.
A total of 584 cases (86%) and 1028 controls (76%) answered
the questionnaire. Thirteen cases with no matched control and 115
controls with no matched case were excluded. Thus, the subjects
actually studied consisted of 571 cases (84% of 674 eligible cases)
and 913 controls (68% of 1348 healthy controls selected).
The following information was collected with regard to sunbed
use: ever exposure; regular exposure; exposure time (i.e. how long
each exposure to sunbed is/was); number of times per week;
number of weeks per year; location of exposure; season when
exposure took place; age at first use; and age at last use. An
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plying number of times per week by number of weeks per year. In
the same manner an estimate of total number of sunbed uses was
calculated by multiplying number of times per year by number of
years of regular use.
No re-examination of the histopathological slides was under-
taken. However, all pathology reports were reviewed to ascertain
that each case had a histopathologically confirmed diagnosis of
invasive malignant melanoma. According to the pathology reports
the diagnoses were superficial spreading melanoma in 309 cases
(54%), nodular melanoma in 76 cases (13%), lentigo maligna
melanoma in 57 cases (10%), acral lentiginous melanoma in three
cases (0.5%) and unclassified invasive malignant melanoma
in 113 cases (20%). Thirteen cases (2%) were incorrectly reported
as invasive malignant melanoma, since they had the diagnosis of
in situ melanoma.
Analyses were performed on histopathologically confirmed
primary cutaneous malignant melanomas with the inclusion of 13
patients with in situ melanoma. Odds ratios (ORs) were computed,
based on matched pairs, using both univariate and multivariate
methods. In the multivariate analyses conditional logistic regres-
sion was used. The multivariate models included adjustments for
hair colour, number of raised naevi, skin reaction to sun exposure
(skin type) and number of sunburns, which were important risk
factors identified in this case–control study as well as in our
previous study (Westerdahl et al, 1994). The inclusions of other
constitutional factors, other sun exposure variables and/or socio-
economic factors into the multivariate models were found to give
no further significant contribution to the chosen model. P-value
less than 0.05 was considered statistically significant and 95%
confidence intervals (CIs) were used. The statistical program Stata
was utilized (Stata Corporation, College Station, TX, USA).
Occasional missing values for some variables caused slight varia-
tions in the numbers of cases and controls used for each analysis.
Cases and controls were not contacted to complement missing
values. However, for almost all variables less than 5% were
missing.
The Ethical Committee of the Medical Faculty of Lund
University approved this study. Informed consent was sought from
the treating physician, the patient and the healthy control.
RESULTS
Among 571 cases (females, 50.3%; males, 49.7%) and 913
controls (females, 50.8%; males, 49.2%), 250 cases (44%) and 372
controls (41%) reported ever using sunbeds. Table 1 shows charac-
teristics of the controls that had ever used sunbeds, separating the
exposure ever use and regular use, past or present (hereafter
referred to as regular use). As can be seen sunbed users reported
more sunbathing occasions during the summer and had more
raised naevi than non-sunbed users. Exposure to sunbeds was also
seen to be more prevalent among younger persons and among
females.
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Table 1 Exposure to sunbeds among controls. The estimated percentages of total number of controls belonging to a given category are given with 95%
confidence intervals
Exposure to sunbeds
Never Sometime Regular (present or past)
Total (n = 910) 59 (56–62) 30 (27–33) 11 (9–13)
Sex
Males (n = 453) 76 (72–80) 25 (21–29) 8 (5–10)
Females (n = 457) 43 (38–47) 41 (36–45) 16 (13–20)
Age
18–35 (n = 87) 20 (11–28) 47 (37–58) 33 (23–43)
36–60 (n = 381) 45 (40–50) 42 (37–46) 14 (10–17)
61–80 (n = 442) 79 (76–83) 16 (13–20) 4 (3–6)
Hair colour
Black/dark brown (n = 240) 60 (54–66) 27 (22–33) 13 (9–17)
Light brown (n = 495) 59 (54–63) 31 (27–35) 10 (8–13)
Blond/fair (n = 110) 56 (46–65) 32 (23–40) 13 (6–19)
Red (n = 39) 56 (41–72) 33 (18–48) 10 (1–20)
Skin reaction to sun exposure
after a few days of exposure
Tan/no burn (n = 118) 58 (49–66) 31 (23–40) 11 (5–17)
Moderate tan (n = 479) 54 (50–59) 34 (30–38) 12 (9–15)
Light tan (n = 272) 64 (58–70) 25 (20–31) 11 (7–14)
No tan (n = 10) 90 (71–100) 10 (0–29) 0
Number of raised naevi
None (n = 770) 63 (60–67) 27 (24–30) 10 (8–12)
1–2 (n = 100) 37 (28–46) 42 (32–52) 21 (13–29)
> 2 (n = 40) 35 (20–50) 55 (40–70) 10 (1–19)
Numbera of sunbathing
occasions during the
summer (April–September)
None (n = 103) 89 (83–95) 8 (3–13) 3 (0–6)
1–14 (n = 294) 67 (62–72) 26 (20–30) 8 (4–10)
³ 15 (n = 485) 46 (42–51) 38 (34–42) 15 (12–19)
a Average past and present number each summer.The exposure to sunbeds was found to have greatly increased
since the early 1980s, with 80% of such exposure among cases and
79% of such exposure among controls, being reported to have
started after 1980. Ninety per cent of cases and 88% of controls,
respectively, reported that they generally exposed the whole body
for 30 min each time they used sunbeds.
The OR for developing malignant melanoma after ever having
used sunbeds was 1.2 (95% CI 0.9–1.6), adjusted for history of
sunburn after age 19 years, hair colour, skin type and number of
raised naevi. In individuals younger than age 36, the OR was
higher (adjusted OR = 3.1, 95% CI 0.7–13.4).
When all cases were considered, an elevated adjusted OR for the
disease after regular exposure was found (adjusted OR = 1.8, 95%
CI 1.2–2.7) (Table 2). Risk for melanoma was associated with
number of sunbed uses per year, total number of times a sunbed
was used and number of years of regular use. However, a
dose–response relationship between total number of sunbed and
risk of malignant melanoma was only found up to the level of 250
times. Above that level the elevated OR decreased and was not
significant. Virtually the same pattern was seen for number of
years of regular use and number of times per year respectively.
Interestingly, a higher risk was related to commercial use of
sunbeds (Table 2). Regular use during the winter was also associ-
ated with an increased OR for melanoma development (adjusted
OR = 2.3, 95% CI 1.3–4.3).
Regular sunbed users who were first exposed before age 36
demonstrated an increased OR for melanoma development (Table
2). Furthermore, in analyses of different age strata, melanoma
patients younger than age 36 years showed the highest OR
(adjusted OR = 8.1, 95% CI 1.3–49.5) for regular exposure to
sunbeds vs. never (Table 3).
Adjusted ORs among men and women were 1.3 (95% CI
0.7–1.7) and 2.1 (95% CI 1.2–3.6), respectively, for regular vs.
never use.
Individuals with black/dark brown or light brown hair had a
higher and statistically significant adjusted OR than individuals
with blond/fair or red hair (adjusted OR = 2.3, 95% CI 1.3–4.0,
and adjusted OR = 1.5, 95% CI 0.2–10.4 respectively, for regular
vs never use). The adjusted ORs for developing melanoma after
regular sunbed use were almost the same among subjects who
reported frequent sunbathing during the summer and those who
did not sunbathe frequently during the summer (adjusted OR = 2.4,
95% CI 1.1–5.1 and adjusted OR = 3.0, 95% CI 0.8–10.8 respec-
tively).
Analyses on sunbed use and risk of melanoma by histologic
type showed similar ORs for the different histologic types, but the
relation was statistically significant only for superficial spreading
melanoma (adjusted OR = 1.8, 95% CI 1.0–3.3). In an analysis of
exposure to sunbeds for subsites of melanoma (Table 4), the
pattern of higher risk of melanoma among those with regular
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Table 2 Odds ratios (OR) for developing cutaneous malignant melanoma in relation to sunbed related variables among regular sunbed users
OR OR-adja Test for trend
Factor and category Cases Controls (95% CI) (95% CI) P-value
Exposure to sunbed
Never 319 538 1.0b 1.0b
Sometime 162 270 1.1 (0.8–1.4) 1.1 (0.8–1.4)
Regular (present or past) 88 102 1.6 (1.1–2.4) 1.8 (1.2–2.7) 0.05
Number of sunbed uses per year
None 319 538 1.0b 1.0b
1–5 9 16 0.8 (0.3–2.6) 1.5 (0.3–6.4)
6–10 20 14 4.1 (1.4–11.9) 4.2 (1.3–13.0)
11–15 14 17 2.2 (0.8–5.8) 2.7 (1.0–8.3)
³20 44 55 1.3 (0.7–2.2) 1.5 (0.8–3.0) 0.06
Number of years of regular use
None 319 538 1.0b 1.0b
1–10 58 65 2.1 (1.2–3.7) 2.7 (1.4–5.4)
>10 28 28 1.5 (0.7–3.2) 1.8 (0.8–4.1) 0.72
Total number of sunbed uses
None 319 538 1.0b 1.0b
1–125 22 32 1.7 (0.8–3.7) 2.8 (1.0–7.8)
126–250 34 31 2.2 (1.1–4.4) 3.1 (1.3–7.1)
>250 31 37 1.3 (0.7–2.5) 1.5 (0.7–3.2) 0.26
Age at first exposure
Never 319 538 1.0b 1.0b
£35 50 56 2.0 (1.2–3.5) 2.3 (1.2–4.2)
>35 38 44 1.6 (0.9–2.5) 1.6 (0.9–2.9)
Location of sunbed usec
Never use 319 538 1.0b 1.0b
At home 34 38 1.3 (0.7–2.5) 1.5 (0.7–3.3)
Outside home 52 64 1.6 (0.9–2.8) 2.2 (1.1–4.4)
Season when exposure took placed
Never use 319 538 1.0b 1.0b
Winter 76 82 1.7 (1.1–2.8) 2.3 (1.3–4.3)
Summer 4 9 0.9 (0.2–3.1) 0.5 (0.1–2.7)
Winter and summer 8 11 1.1 (0.4–3.4) 1.4 (0.4–4.8)
a Adjusted for hair colour, number of raised naevi, skin type and number of sunburns. bReference category. cThe place where sunbed exposure mainly take/took
place. dThe season when sunbed exposure mainly take/took place. Winter refers to October to March, while summer designates April to September.sunbed use was seen for lesions of the trunk, upper and lower
extremities. However, the latter association was the only one that
reached statistical significance (adjusted OR = 2.1, 95% CI
1.1–4.2). When men and women were considered separately,
lesions of the lower extremities showed the strongest associated
with use of sunbeds in women (adjusted OR = 2.7, 95% CI
1.1–6.8) while no significant association was seen between sunbed
use and anatomic site in men.
It is arguable that adjusting for naevi may be overmatching.
However, adjusting for raised naevi did not appreciably affect the
results, speaking against overmatching.
Analyses adjusted for other aspects of sun exposure gave virtu-
ally the same ORs. For instance, in a similar multivariate model as
the one concerning ‘Exposure to sunbed’ in Table 2, the OR for
developing melanoma after regular sunbed use was 1.8 (95% CI
1.2–2.7) when adjusting for sunbathing vacations abroad, and 1.9
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Table 3 Odds ratios (OR) for developing cutaneous malignant melanoma in relation to regular use of sunbeds in different agea groups
OR ORadjb
Factor and category Cases Controls (95% CI) (95% CI) Test for trend
P-value
Patients younger than age 36 years
Exposure to sunbed
Never 6 17 1.0c 1.0c
Sometime 23 41 1.8 (0.6–5.5) 2.8 (0.6–12.4)
Regular (present or past) 28 29 4.2 (1.2–15.6) 8.1 (1.3–49.5) 0.04
Patients between ages 36 and 60 years
Exposure to sunbed
Never 94 170 1.0c 1.0c
Sometime 95 158 1.1 (0.8–1.6) 1.2 (0.8–1.8)
Regular (present or past) 47 53 1.7 (1.0–2.8) 2.2 (1.2–3.9) 0.07
Patients older than age 60 years
Exposure to sunbed
Never 219 351 1.0c 1.0c
Sometime 44 71 1.0 (0.7–1.6) 0.8 (0.5–1.4)
Regular (present or past) 13 20 1.0 (0.5–2.1) 0.9 (0.4–2.2) 0.95
aAge at diagnosis. bAdjusted for hair colour, number of raised naevi, skin type and number of sunburns. cReference category.
Table 4 Odds ratios (ORs) and 95% confidence intervals (CI) for subgroups of melanoma by body site in relation to use of sunbeds
Factor and category Males Females Total (males + females)
OR adja Trend test OR adja Trend test OR adja Trend test
(95% CI) P-value (95% CI) P-value (95% CI) P-value
Primary melanoma of the face and neck
(39 males and 39 females)
Exposure to sunbed
Never 1.0b 1.0b 1.0b
Sometime 0.2 (0.01–2.7) 0.6 (0.1–2.7) 0.4 (0.1–1.4)
Regular 0.8 (0.04–19.5) 0.78 0.6 (0.1–5.6) 0.05 0.5 (0.1–2.4) 0.03
Primary melanoma of the trunk
(170 males and 96 females)
Exposure to sunbed
Never 1.0b 1.0b 1.0b
Sometime 1.2 (0.7–2.2) 0.7 (0.3–1.4) 0.9 (0.6–1.4)
Regular 1.5 (0.5–4.4) 0.02 1.6 (0.6–4.0) 0.36 1.8 (0.9–3.3) 0.06
Primary melanoma of the upper extremities
(41 males and 41 females)
Exposure to sunbed
Never 1.0b 1.0b 1.0b
Sometime 1.0 (0.3–3.0) 1.1 (0.2–5.7) 0.8 (0.3–2.0)
Regular 0.9 (0.1–7.6) 0.20 2.7 (0.3–21.5) 0.02 1.6 (0.4–6.1) 0.04
Primary melanoma of the lower extremities
(27 males and 109 females)
Exposure to sunbed
Never 1.0b 1.0b 1.0b
Sometime 2.8 (0.4–8.2) 1.7 (0.8–3.5) 1.7 (0.9–3.1)
Regular 2.7 (0.2–20.0) 0.11 2.7 (1.1–6.8) 0.23 2.4 (1.1–5.7) 0.14
aAdjusted for hair colour, number of raised naevi, skin type and number of sunburns. bReference category.(95% CI 1.2–2.8) when controlling for sunbathing frequency
during the summer. In the same manner adjustments for other
constitutional factors and/or socio-economic variables gave essen-
tially the same results. Furthermore, when the 13 cases with in
situ melanoma were excluded from the analyses the results were
unaltered.
DISCUSSION
The results of the present report point to a relation between sunbed
use and malignant melanoma.
A very important issue when interpreting results on the associa-
tion between use of sunbeds and melanoma development is the
possibility of confounding by sun exposure. This potential
confounding is of especial concern since it has been shown, like in
the present study, that sunbed use correlate strongly with tanning
in natural sunlight (Autier et al, 1991; Lillquist et al, 1994;
Boldeman et al, 1997). Consequently the pattern of sunbed use
might affect the risk of melanoma by the use per se, by being a
surrogate for intermittent exposure to sunlight or by increasing the
total UV dose received. In order to try separating the effect of
sunbed use alone from that of sun exposure for the development of
melanoma, the analyses were carefully adjusted for different sun
exposure variables. However, the association between use of
sunbed and malignant melanoma persisted after these adjustments.
Even in analyses stratified by sunbathing habits the ORs turned out
to be essentially the same.
A drawback of the present study is the lack of information on
the types of lamp used and thus intensity and spectral outputs of
the devices to which exposure had occurred. However, it is diffi-
cult, if not impossible, in a retrospective study design to collect
detailed information on output spectra and intensity and at the
same time expect high recall and minimum of memory bias.
Furthermore, the nature of the sunlamps has changed over time,
which makes it even more difficult. The lamps in use before the
late 1970s produced significant fractions of UV-B (22–40%) and
UV-C (0.1–20%) (Diffey and Farr, 1991). Since the early 1980s
the devices produce mainly UV-A, but also a small fraction of UV-
B (< 0.1–2.1%) (Diffey and Farr, 1991) since it produces a more
substantial tan than UV-A. In recent years the fraction of UV-B
produced by these devices has increased in Sweden (Swedish
Radiation Protection Institute, personal communication). Yet, in
the present study we do know that the tanning was for non-medical
reason, that 80% of exposure started after 1980 and that approxi-
mately 90% had whole-body exposure for 30 min each time. We
therefore believe that the subjects in this study were mostly
exposed to devices mainly emitting UV-A.
The present results are in accordance with our previous results
from South Sweden (Westerdahl et al, 1994), as well as results
from Scotland (Swerdlow et al, 1988), Canada (Walter et al, 1990),
and Belgium, France and Germany (Autier et al, 1994). All these
studies have mainly come from areas with relatively low ambient
UV radiation. They have all pointed to an association between use
of sunbeds/sunlamps and malignant melanoma with some form of
dose–response relation. Interestingly, in the present study this
dose–response relationship only existed to a certain level above
which the ORs decreased and became non-significant.
Unfortunately the relationship between burns due to use of
sunbeds and melanoma could not be assessed since only informa-
tion on sunburns was recorded. Autier et al (1994) reported a
strong association between burns due to sunlamp or sunbed
exposure and melanoma.
Our results demonstrated higher risks both among those who
started to use sunbeds earlier in life and among those diagnosed
with melanoma at an earlier age. Previous studies have shown
similar results (Chen et al, 1998; Swerdlow et al, 1988; Walter
et al, 1990; Westerdahl et al, 1994). These findings may not be
surprising since sunbed use is particularly common in teenagers
and young adults (Boldeman et al, 1996) and the high OR might
then be due to the high exposure in this age group per se. In addi-
tion, exposure at a younger age may have a greater impact on later
melanoma development. Thus the lag period between onset of
exposure and the occurrence of melanoma might not be that long
after all.
To find out if the relation between sunbed use and risk for
melanoma development differ according to sun sensitivity, a
stratified analysis by hair colour was performed. A significantly
increased odds ratio was only seen among subjects with black/dark
brown or light brown hair. Additional subgroup analysis showed
that an increased melanoma risk was associated with sunbed use
outside home. Two previous studies have reported a higher risk
with domestic use of sunbeds or sunlamps (Walter et al, 1990;
Chen et al, 1998). However, others have suggested that the danger
might be greater in the commercial sector because the output for
both UV-A and UV-B are higher (Wright et al, 1997). There was a
significant relation between exposure to sunbed during the winter
and melanoma. This observation is most interesting since it is
reasonable to presume that during the winter the skin of most
individuals in our country is less adapted to UV radiation than in
the summer.
In contrast to our previous study (Westerdahl et al, 1994) lesions
of the legs were those that showed the strongest association of
increased risk with sunbed use. The use of sunbeds was only
borderline significantly associated with lesions of the trunk. This
observation is most interesting since exposure to sunbeds was seen
to be more prevalent among females. It was associated with
increased risk for developing melanoma in females but not in men.
Melanomas appear most frequently on the lower limbs in females.
Finally, the age-standardized incidence rates have particularly
increased for cutaneous malignant melanoma of the trunk in both
men and women and of the leg in women (Østerlind et al, 1988a;
Thörn et al, 1990). Walter et al (1990) found that the sunbed-
related risk was greater for men and for melanoma of the
face/head/neck and arms.
Five additional studies have reported limited (Chen et al, 1998)
or no evidence of an association between sunlamp/sunbed use and
malignant melanoma (Gallagher et al, 1986; Holman et al, 1986;
Østerlind et al, 1988b; MacKie et al, 1989). However, most of
these studies were based on relatively small number of subjects
who were exposed to sunbeds and have presented very limited
information on sunbed use. The present study provides more
detailed exposure data.
In addition to the epidemiological evidence presented, it seems
biologically plausible that exposure to sunbeds could increase the
risk of melanoma since UV-A, like UV-B, has been classified as
‘probably carcinogenic to humans’ (IARC, 1992). A recent study
has also shown a significant increase in risk of cutaneous
melanoma among patients treated with oral psoralen and UV-A
radiation (Stern et al, 1997). However, the study by Stern and co-
workers did not report the total phototoxic dose delivered to their
patients or if the melanoma patients were at greater risk for
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suggested that UV-A sunbeds may cause melanocytic lesions with
malignant potential (Jones et al, 1987; Williams et al, 1988).
Lastly, the only existing animal model of melanoma for which an
action spectrum has been estimated, the platyfish-swordtail hybrid
model, shows that UV-A exposure may be more important than
UV-B (Setlow et al, 1993). Indeed, in terms of biologically effec-
tive doses (applying action spectra for the platyfish-swordtail
hybrid model), frequent sunbed use can increase the annual effec-
tive dose as much as six times what would be received from the
sun alone (Miller et al, 1998). When considering all these data
together, it may be tempting to suggest that primarily UV-A and
not UV-B is associated with the development of melanoma. This is
in accordance with a new hypothesis for melanoma induction,
which proposes that radiation absorbed by the melanin in
melanocytes generates products that may activate the carcinogenic
process (Moan et al, 1999). This is thought to be true especially for
UV-A radiation since it penetrates the skin deeper and better than
UV-B radiation.
To reduce the likelihood of selection bias, the study had a
population-based design. Furthermore, the response rate was
reasonably good. There is also no a priori reason to suspect that
identified risk factors in this study are associated with non-
participation.
In order to reduce measurement errors attention was paid to
defining variables in such a way that one could expect high recall
with minimum of memory bias. Indeed, a similar questionnaire
has been found to yield information with good test–retest relia-
bility (Westerdahl et al, 1996). Still, the influence of non-differen-
tial misclassification (i.e. measurement error that is independent of
disease status) may have been considerable, since for instance the
exposure variable sunbed use most likely included a heteroge-
neous sample of devices. However, it is widely appreciated that
non-differential misclassification leads to an underestimation of a
true relationship. A particular concern in case–control studies is
recall bias (i.e. if cases report differently than controls), since it
can distort associations in an unpredictable manner (Copeland
et al, 1977). We used identical procedures of data collection for
cases and controls. In addition, information from cases was
collected close in time to the diagnosis in order to avoid the influ-
ence, which the diagnosis of melanoma may have on recall of
sunbed use. Nevertheless, it can not be solely ruled out that aware-
ness of the diagnosis of malignant melanoma and the hypothesis of
an association between sunbed use and melanoma occurrence may
have perverted the answers to the questions on sunbed use.
However, in the present study the estimated risks were virtually
the same as those obtained when the general population was
unaware of the hypothesis (Westerdahl et al, 1994). Moreover, a
higher rate of both cases and controls reported exposure to
sunbeds in the present study (cases: 44%; controls: 41%)
compared to our previous study (cases: 29%; controls: 24%). We
therefore do not think that reporting errors differs between cases
and controls.
In conclusion, although it is not possible to entirely rule out that
the observed relationship may be partly explained by residual
confounding of inadequate measurement of sun exposure the
present results substantiate the hypothesis that exposure to
sunbeds might increase the risk of developing malignant
melanoma. Such relationship is of serious concern because of the
widespread use of sunbeds in the modern societies. Our results are
in accordance with the assumption that UV-Amay be more impor-
tant than UV-B for melanoma induction.
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